GALVUS OD 100 15S

About

GALVUS OD 100 contains vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, used in the management of type 2 diabetes mellitus. Vildagliptin works by enhancing the body's natural ability to control blood glucose levels. It achieves this by increasing the levels of active incretin hormones, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones play a crucial role in glucose homeostasis by stimulating insulin secretion from pancreatic beta cells in a glucose-dependent manner and by suppressing glucagon secretion from pancreatic alpha cells. This dual action helps to reduce both fasting and post-meal blood glucose concentrations, leading to improved glycemic control. It is often prescribed when diet and exercise alone are insufficient, or in combination with other antidiabetic agents.

Uses

• Management of type 2 diabetes mellitus.
• As monotherapy when metformin is inappropriate.
• In combination with other oral antidiabetic agents.
• Adjunct to diet and exercise for glycemic control.

Directions For Use

Take one tablet orally once daily, with or without food, as directed by your physician.

Benefits

• Effectively lowers blood glucose levels.
• Improves insulin secretion in a glucose-dependent manner.
• Reduces inappropriate glucagon secretion.
• Generally associated with a low risk of hypoglycemia.
• Can be used as monotherapy or in combination.
• Helps achieve better long-term glycemic control.

Side Effects

• Nasopharyngitis
• Headache
• Dizziness
• Tremor
• Fatigue
• Nausea
• Diarrhea
• Constipation
• Abdominal pain
• Rash
• Peripheral edema
• Rare cases of pancreatitis

Safety Measures

• Alcohol - Moderate alcohol consumption is generally considered safe, but excessive intake can affect blood sugar levels and should be discussed with a healthcare provider.
• Pregnancy - Consult your doctor before use. This medication is generally not recommended during pregnancy unless the potential benefits outweigh the risks to the fetus.
• Breastfeeding - Not recommended during breastfeeding as it is unknown if vildagliptin is excreted in human milk. Consult your physician.
• Liver - Not recommended for patients with severe hepatic impairment. Liver function tests should be monitored before and during treatment.
• Kidney - Dose adjustment may be necessary for patients with moderate to severe renal impairment. Consult your doctor for appropriate dosing.
• Lung - No specific contraindications related to lung conditions, but monitor for any respiratory infections or exacerbations.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.